Please login to the form below

Not currently logged in
Email:
Password:

Teprotumumab

This page shows the latest Teprotumumab news and features for those working in and with pharma, biotech and healthcare.

FDA approves Horizon's thyroid eye disease drug ahead of schedule

FDA approves Horizon's thyroid eye disease drug ahead of schedule

The US Food and Drug Administration (FDA) was due to deliver a verdict on Tepezza (teprotumumab-trbw) on 8 March. ... We believe teprotumumab may impact underlying mechanisms of fibrosis and could demonstrate utility beyond thyroid eye disease,

Latest news

  • Horizon looks bright as FDA panel backs eye drug teprotumumab Horizon looks bright as FDA panel backs eye drug teprotumumab

    took intravenous teprotumumab meeting the primary endpoint of a 2mm reduction in eyeball protrusion, compared to 9.5% of the control arm. ... Teprotumumab has breakthrough therapy, orphan drug and fast track designations from the FDA.

  • Horizon sunny as thyroid eye disease drug hits the mark Horizon sunny as thyroid eye disease drug hits the mark

    Eye specialist Raymond Douglas of Cedars-Sinai Medical Centre in the US, one of the principal investigators in the trial, said that the reduction in proptosis with teprotumumab was “unprecedented”. ... If approved, teprotumumab would give physicians

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...